Are You Ready to Make Real Money?

Recs

11

Thanks to the recent rally, you may be feeling pretty good about yourself. After all, Dow members such as American Express (NYSE: AXP) and DuPont (NYSE: DD) are up 20% or more year to date. If you're new to the market, you may be thinking this stock-picking stuff is easy money.

It's not -- and this recent rally cannot continue. It's not in the nature of U.S. large caps to offer such enormous returns in such a short period of time. This market is seriously out of whack.

That makes no sense
And while Fed Chairman Ben Bernanke has declared the recession "very likely over," unemployment still hovers close to 10%, the credit markets are still anemic, and consumer activity is being subsidized by the government.

You may say, "Yeah, but the market is forward-looking." Sure it is, but it's not that forward-looking. Tack on the inflation that's likely to result from rampant deficit spending and, well, tread carefully in U.S. stocks.

What you can do
It's for these reasons that we continue to look outside the U.S. for compelling stock ideas at Motley Fool Global Gains, and why we're particularly excited about the opportunities in China, Brazil, India, and Chile.

Stocks in these countries today offer better valuations relative to their growth prospects. And the advantages over the U.S. aren't necessarily the same from country to country.

India has a younger workforce; Chile a large budget surplus and abundant natural resources; China a massive population with significant personal savings; and Brazil a growing resource economy that is developing stronger and stronger ties with China. Thus, these countries can hold up to some degree even as the U.S. falters, though complete decoupling is unlikely.

Tiny China Marine Food (AMEX: CMFO) trades for just 1.8 times sales and 7.4 times EBITDA. Yet this is a company that is growing quickly, should end the year with $40 million in net cash, and continues to sign new distribution deals for its snack foods.

Yet if you look up Yanglin Soybean, you may be scared off. It only recently listed with AMEX, the stock is somewhat illiquid, and the company is contemplating raising $40 million in equity. There's no way to be sure that the company will spend this shareholder money well.

It's time to take off the training wheels
These are legitimate concerns. But I've already tried to assuage them. So, today, I point you to Baupost Group's Seth Klarman's 1997 letter to shareholders:

I frequently hear the argument that the rules are different overseas: the accounting murky, the annual reports unreadable, the currencies sometimes unhedgable. All of these points are fair, but, rather than being arguments to avoid foreign markets, they are instead arguments to embrace them. After all, as an investor you never have perfect information, and the biggest profits are always available (just as they have been in the U.S.) when competition and information are scarce. The payoff to fundamental analysis rises proportionately with the difficulty of performing it.

Yes, I added that emphasis, but only because it's such a key point. Klarman goes on to say that the highest return -- the real money -- is made in markets where information is scarce and management teams are not yet obviously shareholder-oriented.

The logical conclusion
Think about that, and decide what kind of investor you're willing and able to be. If you're satisfied with average returns, buy an index fund and enjoy the 5% or so annual gains you'll reap from core holdings in Johnson & Johnson (NYSE: JNJ) and IBM (NYSE: IBM). And yes, you're getting those same kinds of big, staid megacaps, even when you purchase an emerging-markets index fund. Top holdings in Vanguard's offering are $200 billion China Mobile (NYSE: CHL) and $45 billion Teva Pharmaceutical (Nasdaq: TEVA) -- an "emerging-markets" company that actually earns the bulk of its revenue in these United States.

If you're looking for more than that, then sign up to get our free real-time dispatches from our upcoming Global Gains research trip to India. We'll be meeting with a collection of promising India companies and in-country analysts and investors who will give us the scoop on the local market.

We take off in less than two weeks, so tell us today where we can send our notes.

This article was first published on May 14, 2009. It has been updated.

Tim Hanson does not own shares of any stocks mentioned. American Express is an Inside Value recommendation and Johnson & Johnson is an Income Investor pick. China Marine is a Global Gains selection. The Fool's disclosure policy is the real deal.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On November 17, 2009, at 8:54 AM, funfundvierzig wrote:

    Foolish Readers,

    In my opinion, DuPont is particularly risky at this price point of circa 35. With the expiration of patents of the two drugs remaining in its phased-out Pharma "platform", Cozaar® and Hyzaar®, DuPont faces a dramatic decline next year, 2010, of $750 million to $800 million in operating earnings. Pharma earnings at this much shrunken old-line chemical conglomerate account for nearly a third of all pre-tax operating income in the current year!

    DISCLOSURE: The undersigned has a small short position in DD. ...funfun..

  • Report this Comment On November 17, 2009, at 9:47 AM, funfundvierzig wrote:

    EDITORIAL CLARIFICATION: DuPont Earnings

    The "dramatic decline next year, 2010, of $750 million to $800 million in operating earnings" in the post above refers to the expected year-over-year decline in DuPont Pharma operating earnings, which currently constitute nearly one-third of all DuPont pretax-tax operating income.

    ...funfun..

  • Report this Comment On November 19, 2009, at 6:22 PM, Funfunchaser wrote:

    Why is this news?

    It has been disclosed in the SEC documents for years!

    It is already factored into the share price along with all the biotech wonders coming down the pike!

    As you well know from your extensive stock market experience, both good news and bad news is factored into the current stock price.

    Finance 101

    Efficient market hypothesis (EMH) formulated by Eugene Fama in 1970, suggests that at any given time, prices fully reflect all available information on a particular stock and/or market. Thus, according to the EMH, no investor has an advantage in predicting a return on a stock price because no one has access to information not already available to everyone else.

Add your comment.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 1044658, ~/Articles/ArticleHandler.aspx, 2/10/2010 10:34:54 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
Is This Bull Over?

By The Motley Fool

Is This Bull Over?

Related Tickers

2/10/2010 10:18 AM
JNJ $62.27 Down -0.49 -0.78%
Johnson & Johnson CAPS Rating: *****
CMFO $6.33 Up +0.06 +0.96%
China Marine Food… CAPS Rating: *****
DD $32.41 Down -0.06 -0.18%
E.I. du Pont de Ne… CAPS Rating: ****
AXP $37.02 Down -0.52 -1.39%
American Express C… CAPS Rating: ***
IBM $123.24 Up +0.03 +0.02%
International Busi… CAPS Rating: ****
TEVA $56.66 Down -0.44 -0.77%
Teva Pharmaceutica… CAPS Rating: *****
CHL $47.66 Down -1.29 -2.64%
China Mobile Ltd.… CAPS Rating: *****

Community: Investing Wiki

Term Of The Hour

Economic cycle: Economic cycle refers to the typical business cycle. In normal times the economy as measured by Gross Domestic Product (GDP) tends to grow at a somewhat faster rate than factors like population growth. Periodically the economy slows down and perhaps even contracts. When the economy contracts for two consecutive quarters, an official recession is declared. Often the Federal Reserve Board uses…

Want to learn more or edit this definition?
Click here to read more!